Utah Medical Products, Inc. (NASDAQ:UTMD) Short Interest Up 16.6% in November

Utah Medical Products, Inc. (NASDAQ:UTMD) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 64,500 shares, an increase of 16.6% from the November 15th total of 55,300 shares. Based on an average daily volume of 22,200 shares, the days-to-cover ratio is presently 2.9 days. Approximately 2.0% of the shares of the company are short sold.

Analysts Set New Price Targets

Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th.

Utah Medical Products Price Performance

NASDAQ UTMD opened at $62.91 on Friday. The company’s 50 day simple moving average is $65.24 and its two-hundred day simple moving average is $66.80. Utah Medical Products has a 1 year low of $62.86 and a 1 year high of $87.00. The stock has a market capitalization of $213.26 million, a PE ratio of 14.73 and a beta of 0.08.

Utah Medical Products Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Monday, December 16th will be given a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 1.94%. The ex-dividend date of this dividend is Monday, December 16th. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. Utah Medical Products’s dividend payout ratio (DPR) is 28.10%.

Hedge Funds Weigh In On Utah Medical Products

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Virtu Financial LLC bought a new stake in shares of Utah Medical Products during the 3rd quarter valued at about $207,000. Barclays PLC raised its stake in Utah Medical Products by 214.1% in the third quarter. Barclays PLC now owns 4,574 shares of the medical instruments supplier’s stock valued at $306,000 after purchasing an additional 3,118 shares in the last quarter. Geode Capital Management LLC lifted its position in Utah Medical Products by 9.6% during the third quarter. Geode Capital Management LLC now owns 97,080 shares of the medical instruments supplier’s stock valued at $6,497,000 after purchasing an additional 8,516 shares during the last quarter. State Street Corp grew its stake in Utah Medical Products by 0.9% in the 3rd quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock worth $5,434,000 after buying an additional 694 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC increased its holdings in shares of Utah Medical Products by 128.3% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier’s stock worth $5,956,000 after buying an additional 50,030 shares during the last quarter. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.